This site uses cookies as explained in our Privacy Policy. If you agree to our use of cookies, please accept, alternatively, you can change your settings and decline.
FUJIFILM Diosynth Biotechnologies undertakes contract development and manufacture of biotherapeutics, with a particular focus on monoclonal antibody products at its Wilton Centre facility. In our latest case study Andy Topping, Chief Scientific Officer for FUJIFILM Diosynth Biotechnologies, talks about the company’s work in contract development and manufacture of biotherapeutics.